GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 744 filers reported holding GLAXOSMITHKLINE PLC in Q3 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $592,000 | -4.4% | 14,525 | -11.1% | 0.20% | -23.6% |
| Q1 2020 | $619,000 | -47.5% | 16,330 | -34.9% | 0.26% | -32.9% |
| Q4 2019 | $1,179,000 | -35.4% | 25,095 | -41.3% | 0.39% | -11.5% |
| Q3 2019 | $1,826,000 | +11.5% | 42,782 | +4.5% | 0.44% | +13.0% |
| Q2 2019 | $1,638,000 | -4.8% | 40,932 | -0.6% | 0.39% | -5.6% |
| Q1 2019 | $1,720,000 | +9.0% | 41,180 | -0.3% | 0.41% | -3.5% |
| Q4 2018 | $1,578,000 | +0.1% | 41,305 | +5.2% | 0.42% | +20.1% |
| Q3 2018 | $1,577,000 | -3.0% | 39,265 | -2.6% | 0.35% | -7.6% |
| Q2 2018 | $1,625,000 | +7.0% | 40,315 | +3.7% | 0.38% | +12.4% |
| Q1 2018 | $1,519,000 | +126.7% | 38,890 | +105.8% | 0.34% | +126.7% |
| Q4 2017 | $670,000 | -46.1% | 18,895 | -38.3% | 0.15% | -46.2% |
| Q3 2017 | $1,243,000 | -5.0% | 30,620 | +0.8% | 0.28% | -7.6% |
| Q2 2017 | $1,309,000 | -0.5% | 30,364 | -2.7% | 0.30% | -3.2% |
| Q1 2017 | $1,316,000 | +21.4% | 31,220 | +10.8% | 0.31% | +10.6% |
| Q4 2016 | $1,084,000 | -15.8% | 28,170 | -5.7% | 0.28% | -11.9% |
| Q3 2016 | $1,288,000 | +4.6% | 29,870 | +5.1% | 0.32% | +0.6% |
| Q2 2016 | $1,231,000 | +262.1% | 28,420 | +238.5% | 0.32% | +261.4% |
| Q1 2016 | $340,000 | +0.6% | 8,395 | 0.0% | 0.09% | +4.8% |
| Q4 2015 | $338,000 | +5.0% | 8,395 | 0.0% | 0.08% | +2.4% |
| Q3 2015 | $322,000 | -7.7% | 8,395 | 0.0% | 0.08% | 0.0% |
| Q2 2015 | $349,000 | -9.8% | 8,395 | 0.0% | 0.08% | -8.9% |
| Q1 2015 | $387,000 | +63.3% | 8,395 | +51.3% | 0.09% | +55.2% |
| Q4 2014 | $237,000 | -53.6% | 5,550 | -50.1% | 0.06% | -55.7% |
| Q3 2014 | $511,000 | -11.0% | 11,125 | +3.5% | 0.13% | -9.7% |
| Q2 2014 | $574,000 | 0.0% | 10,750 | 0.0% | 0.14% | -8.8% |
| Q1 2014 | $574,000 | -0.9% | 10,750 | -0.9% | 0.16% | +3.2% |
| Q4 2013 | $579,000 | -15.1% | 10,850 | -20.2% | 0.15% | -21.8% |
| Q3 2013 | $682,000 | – | 13,600 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |